Cargando…

Long-Term Safety and Tolerability of Daridorexant in Patients with Insomnia Disorder

BACKGROUND AND OBJECTIVE: Daridorexant is a dual orexin receptor antagonist for the treatment of insomnia. In two phase III, 12-week studies in patients with insomnia disorder, daridorexant improved sleep and daytime functioning while maintaining a favorable safety profile. The objective of this 40-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kunz, Dieter, Dauvilliers, Yves, Benes, Heike, García-Borreguero, Diego, Plazzi, Giuseppe, Seboek Kinter, Dalma, Coloma, Preciosa, Rausch, Magdalene, Sassi-Sayadi, Mouna, Thein, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829592/ https://www.ncbi.nlm.nih.gov/pubmed/36484969 http://dx.doi.org/10.1007/s40263-022-00980-8

Ejemplares similares

Number, Duration, and Distribution of Wake Bouts in Patients with Insomnia Disorder: Effect of Daridorexant and Zolpidem
por: Di Marco, Tobias, et al.
Publicado: (2023)

Meaningful Within-Patient Change on the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ): Analysis of Phase III Clinical Trial Data of Daridorexant
por: Phillips-Beyer, Andrea, et al.
Publicado: (2023)

Efficacy and Safety of Daridorexant in Older and Younger Adults with Insomnia Disorder: A Secondary Analysis of a Randomised Placebo-Controlled Trial
por: Fietze, Ingo, et al.
Publicado: (2022)

Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)
por: Hudgens, Stacie, et al.
Publicado: (2020)

Summary of Research: Development and Validation of the Insomnia Daytime Symptoms and Impacts Questionnaire (IDSIQ)
por: Hudgens, Stacie, et al.
Publicado: (2023)

Daridorexant in Insomnia Disorder: A Profile of Its Use
por: Nie, Tina, et al.
Publicado: (2023)

Correction to: Daridorexant in Insomnia Disorder: A Profile of Its Use
por: Nie, Tina, et al.
Publicado: (2023)

Comparison of sleep microarchitecture in screen failure subjects with insomnia complaints and randomized subjects from two phase 3 studies on insomnia disorder
por: Di Marco, T., et al.
Publicado: (2023)

Preferences of patients for benefits and risks of insomnia medications using data elicited during two phase III clinical trials
por: Heidenreich, Sebastian, et al.
Publicado: (2022)

Use of Daridorexant among Patients with Chronic Insomnia: A Retrospective Observational Analysis
por: Williams, Scott G., et al.
Publicado: (2023)

Daridorexant: First Approval
por: Markham, Anthony
Publicado: (2022)

Nonclinical pharmacology of daridorexant: a new dual orexin receptor antagonist for the treatment of insomnia
por: Roch, Catherine, et al.
Publicado: (2021)

Daridorexant, a Recently Approved Dual Orexin Receptor Antagonists (DORA) in Treatment of Insomnia
por: Sarathi Chakraborty, Dwaipayan, et al.
Publicado: (2023)

Correction to: Daridorexant: First Approval
por: Markham, Anthony
Publicado: (2022)

Daridorexant for the treatment of insomnia disorder: A systematic review and meta-analysis of randomized controlled trials
por: Jiang, Feiyu, et al.
Publicado: (2023)

A Comprehensive Review of Daridorexant, a Dual-Orexin Receptor Antagonist as New Approach for the Treatment of Insomnia
por: Ziemichód, Wojciech, et al.
Publicado: (2022)

Pharmacokinetics of daridorexant, a dual orexin receptor antagonist, are not affected by renal impairment
por: Berger, Benjamin, et al.
Publicado: (2021)

Driving Performance after Bedtime Administration of Daridorexant, Assessed in a Sensitive Simulator
por: Muehlan, Clemens, et al.
Publicado: (2022)

Population pharmacokinetic modeling of daridorexant, a novel dual orexin receptor antagonist
por: Krause, Andreas, et al.
Publicado: (2022)

Complaints of daytime sleepiness, insomnia, hypnotic use, and risk of dementia: a prospective cohort study in the elderly
por: Cavaillès, Clémence, et al.
Publicado: (2022)

What evidence is there for implicating the brain orexin system in neuropsychiatric symptoms in dementia?
por: Bergamini, Giorgio, et al.
Publicado: (2022)

Mapping the insomnia patient journey in Europe and Canada
por: O’Regan, David, et al.
Publicado: (2023)

Insomnia, anxiety, and depression during the COVID-19 pandemic: an international collaborative study
por: Morin, Charles M., et al.
Publicado: (2021)

Insomnia, Daytime Sleepiness and Cardio-Cerebrovascular Diseases in the Elderly: A 6-Year Prospective Study
por: Jaussent, Isabelle, et al.
Publicado: (2013)

French Language Online Cognitive Behavioral Therapy for Insomnia Disorder: A Randomized Controlled Trial
por: Lopez, Régis, et al.
Publicado: (2019)

Social Jetlag Changes During the COVID-19 Pandemic as a Predictor of Insomnia – A Multi-National Survey Study
por: Brandão, Luiz Eduardo Mateus, et al.
Publicado: (2021)

Insomnia with objective short sleep duration is associated with longer duration of insomnia in the Freiburg Insomnia Cohort compared to insomnia with normal sleep duration, but not with hypertension
por: Johann, Anna F., et al.
Publicado: (2017)

Chronic Insomnia Disorder across Europe: Expert Opinion on Challenges and Opportunities to Improve Care
por: Ellis, Jason, et al.
Publicado: (2023)

Insomnia in neurological diseases
por: Mayer, Geert, et al.
Publicado: (2021)

Evaluating the Safety Profile of Non-Active Implantable Medical Devices Compared with Medicines
por: Pane, Josep, et al.
Publicado: (2016)

The association between insomnia and cardiovascular diseases
por: Spiegelhalder, Kai, et al.
Publicado: (2010)

Evaluating Social Media Networks in Medicines Safety Surveillance: Two Case Studies
por: Coloma, Preciosa M., et al.
Publicado: (2015)

No Impaired Glucose Tolerance in Primary Insomnia Patients with Normal Results of Polysomnography
por: Tschepp, Johanna, et al.
Publicado: (2017)

Why Treat Insomnia?
por: Perlis, Michael L., et al.
Publicado: (2021)

Management of insomnia: update and new approaches
por: Unbehaun, Thomas, et al.
Publicado: (2010)

Car Crashes and Central Disorders of Hypersomnolence: A French Study
por: Pizza, Fabio, et al.
Publicado: (2015)

To Increase Our Knowledge on Sleep, Sleep Disorders, and Chronobiology in the Neuroscience Field during the Next Decade
por: Dauvilliers, Yves
Publicado: (2017)

NSAIDs, statins, low-dose aspirin and PPIs, and the risk of oesophageal adenocarcinoma among patients with Barrett's oesophagus: a population-based case–control study
por: Masclee, Gwen M C, et al.
Publicado: (2015)

Can Electronic Health Records Databases Complement Spontaneous Reporting System Databases? A Historical-Reconstruction of the Association of Rofecoxib and Acute Myocardial Infarction
por: Patadia, Vaishali K., et al.
Publicado: (2018)

Insomnia in Pregnancy and Factors Related to Insomnia
por: Kızılırmak, Aynur, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_l2tvqm186nbge3p8uliu491ku7